Lv1
46 积分 2024-03-26 加入
Efficacy of multi-cycle Efgartigimod in achieving minimal symptom expression in myasthenia gravis: A comparative multi-center study
7天前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
27天前
已完结
Secondary Prevention after Ischemic Stroke
28天前
已完结
Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial
1个月前
已关闭
Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials
1个月前
已完结
Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia
1个月前
已完结
Exercise and smoking: health rivals revealing shared protective mechanisms in Parkinson’s?
1个月前
已完结
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism
1个月前
已完结
The US Parkinson's disease community demands prevention
1个月前
已完结
New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment
1个月前
已完结
皖公网安备34019202002308
